| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.28 | 7e-08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |